Text & Content Analysis
This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
Explore by Category
Corpus KPIs
Publisher
pharmaceutical-technology.com
Articles
1
From
2026-07-22 14:12:20+00
To
2026-07-22 14:12:20+00
Range
2026-06-22 22:53:33.089418+00 →
2026-07-22 22:53:33.089418+00
Who’s being talked about
Top Entities
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| belgium | GPE | 1 | 📊 🔍 🧲 |
| bio campus iii | PERSON | 1 | 📊 🔍 🧲 |
| california | GPE | 1 | 📊 🔍 🧲 |
| cdmo | GPE | 1 | 📊 🔍 🧲 |
| choi | ORG | 1 | 📊 🔍 🧲 |
| comment samsung biologics | PERSON | 1 | 📊 🔍 🧲 |
| critical medicines act | ORG | 1 | 📊 🔍 🧲 |
| dominic tyer | PERSON | 1 | 📊 🔍 🧲 |
| ema | ORG | 1 | 📊 🔍 🧲 |
| eu | ORG | 1 | 📊 🔍 🧲 |
| europe | LOC | 1 | 📊 🔍 🧲 |
| fda | ORG | 1 | 📊 🔍 🧲 |
| france | GPE | 1 | 📊 🔍 🧲 |
| globaldata | ORG | 1 | 📊 🔍 🧲 |
| glp1s | PRODUCT | 1 | 📊 🔍 🧲 |
| gmp | ORG | 1 | 📊 🔍 🧲 |
| gsk | ORG | 1 | 📊 🔍 🧲 |
| healthcare | ORG | 1 | 📊 🔍 🧲 |
| incheon | ORG | 1 | 📊 🔍 🧲 |
| india | GPE | 1 | 📊 🔍 🧲 |
| james choi | PERSON | 1 | 📊 🔍 🧲 |
| lilly gateway labs | ORG | 1 | 📊 🔍 🧲 |
| maryland | GPE | 1 | 📊 🔍 🧲 |
| maryland samsungs | ORG | 1 | 📊 🔍 🧲 |
| md | GPE | 1 | 📊 🔍 🧲 |
Who’s talking
Top Sources (Domains)
| Domain | Articles | % | Actions |
|---|---|---|---|
|
|
1 | 100.00 | 📊 📰 🧲 |
Articles included
Top entities
Top sources
Top narrative frames
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-07-22 14:12:20+00 | Business |
|
Samsung Biologics: geographic diversification is a sound business decision | Analyze | Dominic Tyer | 😐 neutral | 0.1096 |